A randomized, multicenter, double-blind, active-controlled, dose-finding phase II study to evaluate the safety and efficacy of oral SCY-078 vs. oral fluconazole in adult female patients of Vulvovaginal Candidiasis (VVC).
Phase of Trial: Phase II
Latest Information Update: 08 Aug 2017
At a glance
- Drugs SCY 078 (Primary) ; Fluconazole
- Indications Vulvovaginal candidiasis
- Focus Therapeutic Use
- Acronyms DOVE
- 08 Aug 2017 New trial record
- 03 Aug 2017 According to a SCYNEXIS media release, first patient has been dosed in this study and top-line results are expected in mid-2018.